Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Patent Issued for Peptides in Diabetes Gene Therapy

A U.S. patent was issued today for synthetic peptides that support gene therapies developed to treat type 2 diabetes and heart failure. . . . → Read More: Patent Issued for Peptides in Diabetes Gene Therapy

Stomach Acid Harnessed to Power Ingestible Devices

Researchers at MIT and Harvard University designed a tiny device that in tests with animals show it can run for days powered by acids in the stomach. . . . → Read More: Stomach Acid Harnessed to Power Ingestible Devices

EU Project to Develop More Versatile Heart Pacemakers

An initiative in Europe plans to design a new type of pacemaker device that adapts to a host of signals in the cardiovascular system and regulates multiple heart functions. . . . → Read More: EU Project to Develop More Versatile Heart Pacemakers

Biopharm, Hospital to Partner on Cell Energy Diseases

A biopharmaceutical company in Sweden and children’s hospital in the U.S. are collaborating on research into deficiencies in cells’ energy components responsible for a number of genetic disorders. . . . → Read More: Biopharm, Hospital to Partner on Cell Energy Diseases

Safer Engineered-Cell Cancer Immunotherapy Designed

A biotechnology company designed a new type of engineered T-cell from the immune system that more precisely targets tumors and stays away from healthy cells. . . . → Read More: Safer Engineered-Cell Cancer Immunotherapy Designed

Electronic Gene Editing Corrects Inherited Blood Disorder

A team at National Institutes of Health used an electronic-aided process to carry out a gene editing technique that in lab mice repaired a genetic defect causing a rare blood disease. . . . → Read More: Electronic Gene Editing Corrects Inherited Blood Disorder

Sanofi Licensing Antibody for Autoimmune Diseases

The global drug company Sanofi is licensing a synthetic antibody to treat autoimmune disorders being developed by a spin-off enterprise from Dartmouth College. . . . → Read More: Sanofi Licensing Antibody for Autoimmune Diseases

Stem Cells Shown to Regenerate Dental Pulp Tissue

A combination of dental pulp stem cells and cells from human umbilical cords, mixed with a common hydrogel, were shown in lab rats to regenerate pulp-like tissue in teeth roots. . . . → Read More: Stem Cells Shown to Regenerate Dental Pulp Tissue

Peptide-Infused Gel Shown to Heal Chronic Wounds

A tissue engineering group developed a gel material infused with a synthetic peptide that in lab cultures and animals healed chronic diabetic wounds faster than a current commercial treatment. . . . → Read More: Peptide-Infused Gel Shown to Heal Chronic Wounds

Synthetic Insulin-Producing Cells Designed, Tested

Synthetic beta cells, like natural cells in the pancreas, were shown in tests with lab mice to sense glucose levels in the blood and produce insulin. . . . → Read More: Synthetic Insulin-Producing Cells Designed, Tested